Replies to post #23703 on Rich Pharmaceuticals Inc. (fka RCHA)

[Axeman]

Not scare tactic just repeat of last two years. Toxic will keep going with GHS since they need money and have nothing yet for a real financing deal.

[wedman]

I’m patient on this !!

[stoprun]

How could a Pharmaceutical company in the Phase I/II study be almost done with conversion, "Show Me The Money", where is the money going to come from for Phase III study and them submission to FDA for approval, to sell to public? I hope you are right, at this point without a joint-venture, how can this happen?

[Peddler22]

Ya I agree. Pretty clean play all around from here and great opportunity to get in, add or cost average (if conversions pushed it down from what you thought was bottom .0007-.001 range) These biotech companies are buy and hold plays as they typically don’t tweet or pr constantly to keep the market involved. You cant wait and climb aboard. When news hits they will fly personally I hope it stays at these levels until I get loaded. Im not in this for a few ticks but a few hundred